Immix Biopharma, Inc.

NASDAQ:IMMX

Biotechnology

Healthcare
$7.04 +0.99%

+$0.09 today

Market cap
$590.04M
Beta
0.10
P/E (TTM)
-10.1
EPS (TTM)
-$0.91
52W Low $1.94High $11.61

Volume 1.13M

Average 1.07M

Balance Sheet

Inspect the capital base behind the business.

Assets

$104.84M

FY 2025 · Annual

+356.9% YoY

Liabilities

$11.04M

FY 2025 · Annual

+13.9% YoY

Equity

$93.80M

FY 2025 · Annual

+607.8% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents17.64M13.44M17.51M17.68M93.93M
Short-term Investments00006.48M
Net Receivables25.72K255.71K1.17M1.97M0
Inventory00000
Other Current Assets516.19K78.07K44.58K32.27K150.72K
Total Current Assets18.19M14.9M19.79M20.2M101.24M
Property, Plant & Equipment (Net)5.7K3.56K50.18K2.73M3.49M
Goodwill00000
Intangible Assets00000
Long-term Investments00000
Tax Assets00000
Other Non-current Assets(0)6.72K87.23K20.42K114.05K
Total Non-current Assets5.7K10.28K137.41K2.75M3.6M
Total Assets18.19M14.91M19.93M22.95M104.84M
Account Payables142.94K143.07K1.43M5.39M5.44M
Short-term Debt50K0000
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities000658.16K0
Total Current Liabilities202.04K1.27M3.72M8.69M10.11M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities0475K000
Total Non-current Liabilities0475K01.01M933.63K
Total Liabilities202.04K1.75M3.72M9.7M11.04M
Common Stock1.32K1.4K2K2.76K5.3K
Retained Earnings(29.76M)(37.99M)(53.41M)(75.02M)(104.46M)
Accumulated OCI125.41K87.02K134.67K(1.06K)60.16K
Other Stockholders Equity00000
Minority Interest00(201.74K)00
Total Equity17.99M13.16M16.2M13.25M93.8M
Total Debt50K001.07M1.07M
Net Debt(17.59M)(13.44M)(17.51M)(16.61M)(92.86M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$79.3M
Short-term Investments$11.3M
Other Current$1.7M
Total Current Assets$92.3M
PP&E (Net)$3.4M
Other Non-current$185.1K
Total Non-current Assets$3.5M
Total Assets$95.8M

Analysis

Selected assets total $95.8M for Latest. The largest visible component is Cash & Equivalents at $79.3M, about 82.7% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
10-QQuarterly reportNov 12, 2026
8-KCurrent reportNov 12, 2026
SC 13GSC 13G filingOct 27, 2026
8-KCurrent reportSep 30, 2026
424B5424B5 filingSep 29, 2026

How much cash does IMMX have?

Immix Biopharma, Inc. (IMMX) reported $93.93M in cash and equivalents in fiscal 2025.

How much debt does IMMX carry?

Immix Biopharma, Inc. (IMMX) reported $1.07M of total debt, with net debt of -$92.86M.